Trinity Biotech (TRIB) Financial Statements & Analysis

Trinity Biotech Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Trinity Biotech plc income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2025	FY 2024	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 2026	Dec 2025	Mar 2025	Dec 2024	Mar 2024	Dec 2023	Dec 2022	Mar 2022	Dec 2021	Dec 2020	Mar 2020	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	43.79	43.79	61.56	61.56	56.83	56.83	62.52	81.15	81.15	101.98	90.44	97.04	99.14
Cost of Revenue	26.90	26.90	40.11	40.11	37.38	37.38	45.25	54.89	47.70	53.40	52.32	55.59	57.25
Gross Profit	16.89	16.89	21.44	21.44	19.45	19.45	17.27	33.45	33.45	48.58	38.12	41.45	41.89
Operating Expenses
Research & Development	3.63	3.63	4.54	4.54	4.38	4.38	4.14	4.50	4.50	5.08	5.33	5.37	5.66
Selling, General & Administrative	24.67	24.67	28.82	28.82	31.15	31.15	26.98	24.68	22.50	25.07	27.58	29.50	30.85
Operating Expenses	28.30	28.30	42.61	42.61	46.50	46.50	30.78	29.52	27.00	30.13	32.82	34.77	36.41
Operating Income	-11.42	-11.42	-21.17	-21.17	-27.05	-27.05	-13.51	3.94	6.45	18.45	0.87	3.30	5.48
Other Income/Expense
Interest Income	0.22	0.22	0.00	-	1.17	1.17	0.30	1.22	0.00	0.04	0.46	2.12	0.81
Interest Expense	13.11	13.11	9.57	-11.91	10.15	-10.15	11.53	7.10	5.45	-5.54	5.58	5.08	5.41
Other Income/Expense	-25.76	-12.67	-9.57	-9.57	-9.88	-9.88	-18.96	-5.86	-2.52	-1.22	-5.89	-2.96	-2.21
Income
Income Before Tax	-37.18	-37.18	-30.73	-30.73	-36.93	-36.93	-43.78	-1.92	-1.92	-6.63	0.82	3.03	1.60
Income Tax Expense	0.20	0.20	0.49	0.49	-0.06	-0.06	-0.19	-0.07	-0.07	-0.62	4.89	0.64	-0.70
Net Income	-37.38	-37.38	-31.79	-31.79	-24.02	-24.02	-41.01	0.88	0.88	-6.39	-4.07	2.39	-40.27
Net Income - Continuous Operations	-37.38	-37.38	-31.79	-31.22	-24.02	-36.87	-43.59	0.88	-1.85	-6.39	-4.07	2.39	-40.27
Net Income - Discontinued Operations	-	-	-	-0.57	-	12.85	2.58	-	2.73	-	-	-	-
EBITDA	-21.38	-21.38	-16.91	-13.03	-24.10	-14.17	-29.92	10.59	6.27	21.52	-19.52	-13.98	-29.27
EBIT	-	-24.06	-	-13.70	-	-15.94	-32.25	-	3.52	18.45	-	-	-
Depreciation & Amortization	2.68	2.68	1.87	0.68	1.78	1.78	2.33	2.74	2.74	3.08	4.89	4.12	5.20
Earnings Per Share
Basic EPS	-60.00	-60.00	-53.00	-53.00	-96.00	-94.00	-182.00	6.00	-	-2.00	-29.00	17.00	-279.00
Diluted EPS	-60.00	-	-53.00	-2.00	-96.00	-4.00	-182.00	5.00	-	-2.00	-24.00	14.00	-225.00
Basic Shares Outstanding	0.62	0.62	0.60	0.60	0.26	0.26	0.22	0.14	4.18	4.18	0.14	0.14	0.14
Diluted Shares Outstanding	0.62	0.62	0.60	0.60	0.26	0.26	0.22	0.18	5.33	4.18	0.17	0.17	0.18

Source: Company financial statements from annual and quarterly filings. Data as of Mar 31, 2026. Data sources and methodology

Frequently Asked Questions About Trinity Biotech Financial Statements

What was Trinity Biotech's revenue in fiscal 2025?

Trinity Biotech reported revenue of $43.78M in fiscal 2025 (fiscal year ended Mar 31, 2026). That was down 28.9% from $61.55M a year earlier.

Is Trinity Biotech profitable?

No. Trinity Biotech reported a net loss of $37.38M in fiscal 2025. In fiscal 2024 it lost $31.79M.

What is Trinity Biotech's operating margin?

Trinity Biotech's operating income was −$11.42M on revenue of $43.78M in fiscal 2025, an operating margin of -26.1%, compared with -34.4% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition